Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,559.1
26.4 (1.04%)

 

  • STI Straits Times Index
    2,559.1
    26.4 (1.04%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,588.6
    20.4 (1.30%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    24,930.6
    -172.0 (-0.69%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,386.5
    8.9 (0.26%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,418.2
    -96.7 (-0.43%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,178.3
    51.2 (1.00%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,345.9M
  • Value: 1,290.1M
  • Rise: 183
  • Fall: 137
  • Unch: 488

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
QT Vascular0.007+0.001
Moya Asia0.072+0.003
Rex Intl0.187+0.001
YZJ Shipbldg SGD0.970+0.035
Oceanus^0.007+0.001
Genting Sing0.710-
Silverlake Axis0.330+0.010
Vicplas Intl0.325+0.090
ISDN0.365-0.005
Synagie0.196+0.002

World Indices

World Indices
Name Last Change
Nasdaq 9,757.2 -259.8
HSI 24,253.8 -296.2
HSCEI 9,745.8 -107.4
Jakarta 4,863.1 -41.0
Nikkei 225 22,064.8 -447.3
SSE Comp 2,959.0 -11.7
Shanghai A 3,101.5 -12.2
Shanghai B 211.6 -1.8
KOSPI 2,100.4 -34.3

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

CHINA BIOLOGIC PRODUCTS HLDGS INC CHINA BIOLOGIC PRODUCTS HOLDINGS
Updated on 05 Aug 2020 (End of trading day)
Last (USD): 107.180 Change: +0.570 High: 107.930 Remarks: -
Change (%): +0.53 Low: 106.520
Open 106.570 Yesterday's Close 106.61000000000001
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 240,038 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a 3.56328 Trailing EPS (USD) e 4.01501 NAV (USD) b 45.1132
PE a 30.079 Trailing PE f 26.695 Price / NAV b 2.3758
Dividend (USD) d - Cash In Hand (USD) g 3.1927 Issued & Paid-up Shares c 38,480,600
Dividend Yield (%) d - Price / Cash In Hand g 33.570 Treasury Shares h 3,450,932
Market Cap (M) 4,124.351 Enterprise Value (M) 3,207.204
Piotroski F Score 5 Exchange Code CBPO Par Value ( $ ) n.a.
52 Weeks Volatility (%) 20.65 Free Float (%) 56.8
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 16 Mar 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 06 Aug 2019.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference CHINA BIOLOGIC PRODUCTS HLDGS INC NASDAQ 4,124.351 30.079 26.695 2.3758 -
Industry Biotechnology NASDAQ 2,927.849 420.477 6455.431 7.5054 0.639
Local Peer AMGEN INC NASDAQ 141,427.530 18.035 19.376 13.2684 2.425
Local Peer GILEAD SCIENCES INC NASDAQ 86,551.530 16.070 - 4.7708 3.686
Local Peer VERTEX PHARMACEUTICAL NASDAQ 71,167.398 60.475 34.202 9.4647 -
Local Peer REGENERON PHARMACEUTICALS INC NASDAQ 70,272.221 33.213 30.831 - -
Local Peer ILLUMINA INC NASDAQ 58,908.780 58.791 62.536 12.7096 -
Local Peer BIOGEN INC NASDAQ 43,721.301 7.425 7.377 3.8662 -
Local Peer MODERNA INC NASDAQ 29,472.859 - - - -
Local Peer SEATTLE GENETICS INC NASDAQ 28,290.172 - - 15.5948 -
Local Peer ALEXION PHARMACEUTICAL INC NASDAQ 22,520.026 9.367 26.616 2.1466 -
Local Peer BIOMARIN PHARMACEUTICAL NASDAQ 21,669.698 - 143.090 - -
Local Peer INCYTE CORPORATION NASDAQ 21,219.952 47.482 - - -
Local Peer BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS NASDAQ 20,435.236 - - 7.2667 -
Other Local Peers BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), EXACT SCIENCES CORP (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), NOVAVAX INC (NASDAQ), IMMUNOMEDICS INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), 10X GENOMICS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), EXELIXIS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), ACCELERON PHARMA (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), FIBROGEN INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), BRIDGEBIO PHARMA INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), RELAY THERAPEUTICS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), ALKERMES PLC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), FATE THERAPEUTICS (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), INSMED INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), VIELA BIO INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), UNIQURE N.V. (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), XENCOR INC (NASDAQ), VAXCYTE INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), VERACYTE INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), CYTOKINETICS INC (NASDAQ), MACROGENICS INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC SPON ADS EACH REP 6 ORD SHS (NASDAQ), EPIZYME INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), COMPUGEN (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), REGENXBIO INC (NASDAQ), CORTEXYME INC (NASDAQ), ARVINAS INC (NASDAQ), NANTKWEST INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), ALECTOR INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), TRANSLATE BIO INC (NASDAQ), RETROPHIN INC (NASDAQ), ITEOS THERAPEUTICS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), MYRIAD GENETICS INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), PRECIGEN INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), NKARTA INC (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), OMEROS CORP (NASDAQ), MORPHIC HOLDING INC (NASDAQ), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), VAXART INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), PERSONALIS INC (NASDAQ), IMMUNOGEN INC (NASDAQ), IMMATICS N V (NASDAQ), AKOUOS INC (NASDAQ), PASSAGE BIO INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), AVROBIO INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), AGENUS INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), GERON CORP (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), PANDION THERAPEUTICS INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), ATHERSYS INC (NASDAQ), ARDELYX INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), PROTHENA CORP PLC (NASDAQ), ANAPTYSBIO INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), XBIOTECH INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), ASPIRA WOMENS HEALTH INC (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), INVENTIVA SA SPON ADS EACH REP 1 ORD SHS (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), KAMADA (NASDAQ), MANNKIND CORPORATION (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), MERUS B V (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), PDL BIOPHARMA INC (NASDAQ), IVERIC BIO INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), IMV INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), AFFIMED N V (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), MEDICINOVA INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), TREVENA INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), NEXTCURE INC (NASDAQ), CHIASMA INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), VERASTEM INC (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), CHIMERIX INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), CABALETTA BIO INC (NASDAQ), ADURO BIOTECH INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), EQUILLIUM INC (NASDAQ), INMUNE BIO INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), XOMA CORP (NASDAQ), OTONOMY INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), CONTRAFECT CORP (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), CELYAD ADS EACH REPR 1 ORD (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), INFLARX N V (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), ORGENESIS INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), LUMOS PHARMA INC (NASDAQ), VACCINEX INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), SAVARA INC (NASDAQ), SESEN BIO INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), RECRO PHARMA INC (NASDAQ), ARAVIVE INC (NASDAQ), RESTORBIO INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), SYNLOGIC INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), CURIS INC (NASDAQ), COHBAR INC (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), SOLIGENIX INC (NASDAQ), OCUGEN INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), BIONANO GENOMICS INC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), PRECIPIO INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), AIKIDO PHARMA INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), ATYR PHARMA INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), ADVAXIS INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), BIOCARDIA INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), EVOGENE LTD (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), CYCLACEL PHARMACEUTICALS INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), ADITX THERAPEUTICS INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), SENESTECH INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ)
Global Peer CSL ASX 126,112.110 47.006 43.535 14.5821 0.955
Global Peer AMGEN-T HKEx 585,694.000 9.532 10.295 7.0897 4.589
Global Peer WUXI BIO HKEx 234,781.111 204.234 204.234 16.4176 -
Global Peer SINO BIOPHARM HKEx 187,027.466 60.936 61.493 5.3982 0.536
Global Peer BEIGENE HKEx 160,090.200 - - 7.3445 -
Global Peer EMERGENT BIOSOLUTIONS INC NYSE 7,116.282 130.574 41.787 5.9362 -
Global Peer Lonza SGX 5,940.891 6.617 5.028 0.6269 4.784
Global Peer GENSCRIPT BIO HKEx 31,817.583 - - 10.6670 -
Global Peer 3SBIO HKEx 24,596.128 22.277 22.277 2.2845 -
Global Peer HAOHAI BIOTEC HKEx 23,524.221 55.952 55.952 3.9995 0.579
Other Global Peers VIVA BIOTECH (HKEx), ALPHAMAB-B (HKEx), MESOBLAST LTD (ASX), MYOVANT SCIENCES LTD (NYSE), ARCUS BIOSCIENCES INC (NYSE), POLYNOVO LIMITED (ASX), ASCENTAGE-B (HKEx), FRONTAGE (HKEx), KINTOR PHARMA-B (HKEx), KADMON HLDGS INC (NYSE), DPHARMA (Bursa), ASCLETIS-B (HKEx), LEE'S PHARM (HKEx), SINOMAB BIO-B (HKEx), IBIO INC (NYSE American), NANOVIRICIDES INC (NYSE American), ESSEX BIO-TECH (HKEx), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), TELIX PHARMACEUTIC (ASX), PFENEX INC (NYSE American), IMUGENE LIMITED (ASX), NEXT SCIENCE LTD (ASX), LINEAGE CELL THERAPEUTICS INC (NYSE American), ENZO BIOCHEM INC (NYSE), CEL-SCI CORP (NYSE American), NEUREN PHARMACEUTICALS LTD (ASX), UNI-BIO GROUP (HKEx), AIM IMMUNOTECH INC (NYSE American), PALATIN TECHNOLOGIES INC (NYSE American), SYNTHETIC BIOLOGICS INC (NYSE American), 22ND CENTURY GROUP INC (NYSE American), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), ARMATA PHARMACEUTICALS INC (NYSE American), ANTEOTECH LIMITED (ASX), IMMUTEP LTD (ASX), MEMPHASYS LTD (ASX), GENETIC TECHNOLOGIES (ASX), ORAGENICS INC (NYSE American), CYNATA THERAPEUTICS LTD (ASX), BIOTRON (ASX), INVEX THERAPEUTICS LTD NPV (ASX), ALTERITY THERAPEUTICS LIMITED (ASX), ACTINIUM PHARMACEUTICALS INC (NYSE American), CT ENTERPRISE (HKEx), KAZIA THERAPEUTICS LIMITED (ASX), BIOSINO BIO-TEC (HKEx), BIONOMICS LTD (ASX), CONSTELLATION TECHNOLOGIES LTD (ASX), REGENEUS LTD (ASX), Suntar Eco-City (SGX), REGENT PACIFIC (HKEx), NOVABAY PHARMACEUTICALS INC (NYSE American), INDIA GLOBALIZATION CAPITAL INC (NYSE American), ACTINOGEN MEDICAL LTD (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), ADALTA LTD (ASX), RHINOMED LIMITED (ASX), HOLISTA COLLTECH LIMITED (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), PATRYS LIMITED (ASX), AMPLIA THERAPEUTICS LTD (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), CRYOSITE (ASX), LIVING CELL TECHNOLOGIES (ASX), ANATARA LIFESCIENCES LTD (ASX), LEAF RESOURCES LTD (ASX), HAO WEN H-NEW (HKEx), FACTOR THERAPEUTICS LIMITED (ASX), NANOLLOSE LTD (ASX), HAO WEN H-OLD (HKEx)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+1.040
+0.98 %
10 Days -+0.600
+0.56 %
20 Days --1.210
-1.12 %
Medium Term Return 3 Months --1.990
-1.82 %
6 Months --9.770
-8.35 %
1 Year -+10.140
+10.45 %
Long Term Return 2 Years -+12.330
+13.00 %
3 Years -+16.010
+17.56 %
5 Years --1.550
-1.43 %
Annualised Return Annualised --
-0.29 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 93.900 - 119.440 Change From 1 Year Low +13.280 % Change From 1 Year Low (%) +14.14
Change From 1 Year High -12.260 % Change From 1 Year High (%) -10.26
2 Years Range 60.080 - 119.440 Change From 2 Years Low +47.100 % Change From 2 Years Low (%) +78.40
Change From 2 Years High -12.260 % Change From 2 Years High (%) -10.26
5 Years Range 60.080 - 144.290 Change From 5 Years Low +47.100 % Change From 5 Years Low (%) +78.40
Change From 5 Years High -37.110 % Change From 5 Years High (%) -25.72
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

China Biologic Products Holdings, Inc. engages in the research, development, manufacture and sale of human plasma-based biopharmaceutical products or plasma products. Its products include plasma and other products. The company was founded in 2002 and is headquartered in Beijing, China.

Historical Price Data

Date Open High Low Close Volume VWAP
05 Aug 2020 106.570 107.930 106.520 107.180 240,038 -
04 Aug 2020 106.690 106.950 105.820 106.610 101,702 -
03 Aug 2020 106.190 107.140 105.300 106.600 93,212 -
31 Jul 2020 106.500 107.120 105.748 106.350 81,031 -
30 Jul 2020 106.040 106.550 105.870 106.140 41,661 -
29 Jul 2020 106.980 106.980 105.450 106.330 65,136 -
28 Jul 2020 107.300 107.300 106.220 106.650 64,682 -
27 Jul 2020 106.910 107.680 106.400 107.100 44,879 -
24 Jul 2020 106.500 107.840 104.685 106.480 133,450 -
23 Jul 2020 107.890 108.410 106.570 106.580 109,733 -
22 Jul 2020 107.510 108.260 107.230 107.680 52,312 -
21 Jul 2020 107.230 109.380 106.890 107.500 63,661 -
20 Jul 2020 107.390 108.420 106.880 107.230 132,937 -
17 Jul 2020 107.870 109.225 107.390 107.430 70,244 -
16 Jul 2020 107.590 108.200 106.870 107.830 71,561 -
15 Jul 2020 107.550 108.135 106.890 107.500 101,872 -
14 Jul 2020 106.210 107.890 106.090 107.280 122,204 -
13 Jul 2020 106.750 108.000 106.230 106.550 110,415 -
10 Jul 2020 108.500 108.790 106.200 106.650 146,320 -
09 Jul 2020 107.810 108.895 107.660 108.390 63,200 -
08 Jul 2020 107.520 108.340 107.250 107.810 118,918 -
07 Jul 2020 106.490 108.360 106.380 106.950 160,662 -
Summary
Current 2 Weeks
(23 Jul 2020 to 05 Aug 2020)
107.890 108.410 104.685 107.180 975,524 -
Previous 2 Weeks
(09 Jul 2020 to 22 Jul 2020)
107.810 108.895 104.685 107.680 934,726 -
4 Weeks from
(10 Jun 2020 to 08 Jul 2020)
107.490 109.050 104.685 107.810 3,083,451 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.